First-Line Durvalumab plus Tremelimumab vs Platinum-Based Chemotherapy for Advanced/Metastatic NSCLC: Phase 3 NEPTUNE Study

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author MOK, Tony
SCHMID, Peter
CASTRO JR., Gilberto De FMUSP-HC
SYRIGOS, Kostas
MARTIN, Claudio
YAMAMOTO, Nobuyuki
AREN, Osvaldo
ARRIETA, Oscar
GOTTFRIED, Maya
JAZIEH, Abdul Rahman
RAMLAU, Rodryg
TIMCHEVA, Constanta
TRANI, Leonardo
dc.date.issued 2017
dc.identifier.citation JOURNAL OF THORACIC ONCOLOGY, v.12, n.1, suppl.S, p.S1084-S1084, 2017
dc.identifier.issn 1556-0864
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/25331
dc.language.iso eng
dc.publisher ELSEVIER SCIENCE INC
dc.relation.ispartof Journal of Thoracic Oncology
dc.rights restrictedAccess
dc.subject MEDI4736; tremelimumab; durvalumab; Checkpoint blockade
dc.title First-Line Durvalumab plus Tremelimumab vs Platinum-Based Chemotherapy for Advanced/Metastatic NSCLC: Phase 3 NEPTUNE Study
dc.type conferenceObject
dc.rights.holder Copyright ELSEVIER SCIENCE INC
dc.description.group LIM/24
dc.type.category meeting abstract
dc.type.version publishedVersion
hcfmusp.author CASTRO JR., Gilberto De:HC:ICESP
hcfmusp.author.external · MOK, Tony:Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
· SCHMID, Peter:Queen Mary Univ London, Barts Canc Inst, Ctr Expt Canc Med, London, England
· SYRIGOS, Kostas:Univ Athens, Athens, Greece
· MARTIN, Claudio:Inst Alexander Fleming, Dept Clin Oncol, Buenos Aires, DF, Argentina
· YAMAMOTO, Nobuyuki:Wakayama Med Univ, Dept Expt Therapeut Internal Med Resp Med & Med O, Wakayama, Japan
· AREN, Osvaldo:Ciec Ctr Int Estudios Clin, Dept Oncol, Santiago, Chile
· ARRIETA, Oscar:Inst Nacl Cancerol Incan, Thorac Oncol Unit, Mexico City, DF, Mexico
· GOTTFRIED, Maya:Meir Med Ctr, Dept Oncol, Kefar Sava, Israel
· JAZIEH, Abdul Rahman:King Saud Univ Hlth Sci Natl Guards Hlth Affairs, Dept Oncol, Riyadh, Saudi Arabia
· RAMLAU, Rodryg:Poznan Univ Med Sci, Dept Oncol, Poznan, Poland
· TIMCHEVA, Constanta:Mhat Womens Hlth, Med Oncol Clin, Sofia, Bulgaria
· TRANI, Leonardo:Astrazeneca, Royston, England
hcfmusp.origem.id WOS:000413055802330
hcfmusp.publisher.city NEW YORK
hcfmusp.publisher.country USA
dc.description.index MEDLINE
dc.identifier.eissn 1556-1380
hcfmusp.citation.wos 1
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country Inglaterra
hcfmusp.affiliation.country Grécia
hcfmusp.affiliation.country Argentina
hcfmusp.affiliation.country Japão
hcfmusp.affiliation.country Chile
hcfmusp.affiliation.country México
hcfmusp.affiliation.country Israel
hcfmusp.affiliation.country Árabia Saudita
hcfmusp.affiliation.country Polônia
hcfmusp.affiliation.country Bulgária
hcfmusp.affiliation.country China


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics